By Sabela Ojea Mirum Pharmaceuticals said the Food and Drug Administration approved Livmarli to treat cholestatic pruritus, a feeling of itchness, in patients five years of age and older with.
Operator: Good afternoon, and thank you all for joining. I would like to welcome you all to the Mirum Pharmaceuticals Report Second Quarter 2023 Financial Results and Provide Business Update.
Operator: Hello. Welcome to Vir Biotechnology Second Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Since Xray and medical reports will be needed for those who have had these medicals submitted to NZ more than 36 months ago medical centres that conduct immigration medicals are already flooded with people seeking appointments to get their Immigration m